Product Images Ondansetron
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Ondansetron NDC 57237-077 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 Tablets Bottle) - ondansetron od fig1
This is a product description for Rising® Noc57237-077-30, which contains 30 orally disintegrating tablets of Ondansetron USP 4 mg each. It contains phenylalanine and should be stored at 20" to 25°C. The product meets USP Disintegration Test 2 and should not be removed from the bottle until immediately before use. Dosage instructions can be found in the package insert. It comes in a tight, light-resistant container and is distributed by Rising Heath, LLC. The product is made in India and has a code of TS/DRUGS/18/1883 with a revised date of 04/2018.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetron od fig2
This is the product label for Rising's Ondansetron Orally Disintegrating Tablets, USP. It contains the product's NDC number, ingredients, dosage form, and the number of tablets included in the package. However, there seems to be a few errors and garbled characters in the text.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg (30 Tablets Bottle) - ondansetron od fig3
Rising® Noc57237-078-30 is a medication distributed in orally disintegrating tablet form, containing Ondansetron USP Ema and 3.37mg of phenylalanine per tablet. The usual dosage is described in the package insert. The tablets meet the USP Disintegration Test 2 and must be stored between 20°C and 25°C with short excursions permitted to 15°C to 30°C. They are dispensed in a tight, light-resistant bottle containing 30 tablets. Instructions on the bottle specify that the tablets should not be removed from the bottle until immediately before use.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetron od fig4
Chemical Structure - ondansetronod str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.